Shares of Humana Inc. are poised to rebound after a rough performance in 2012, thanks in part to growth prospects for the health insurer's Medicare Advantage plans, according to a Bernstein Research analyst.
The Louisville, Ky., company's stock sank 22 percent last year to close at $68.63. In contrast, the Standard & Poor's 500 index rose more than 13 percent.
Analyst Ana Gupte said in a Thursday morning research note she has a $95 price target on the stock, and she expects 2013 earnings of $9.20 per share, which far exceeds the company's initial forecast for earnings of between $7.60 and $7.80 per share. The insurer expects 2012 earnings of $7.25 to $7.35 per share.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
